Comparative Efficacy and Safety of Intravenous Verapamil and Diltiazem for Rate Control in Rapidly Conducted Atrial Fibrillation and Atrial Flutter

J Gen Intern Med. 2020 Dec;35(12):3721-3723. doi: 10.1007/s11606-020-06051-2. Epub 2020 Jul 24.

Authors

Furqan A Rajput¹, Lianlian Du², Richard J Chappell², Theodore J Berei³, Zachary D Goldberger³, Jennifer M Wright³

Affiliations

¹ Department of Medicine, University of Wisconsin School of Medicine & Public Health, Madison, WI, USA. frajput@wisc.edu.
² Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, WI, USA.
³ Department of Medicine, Division of Cardiovascular Medicine, University of Wisconsin School of Medicine & Public Health, Madison, WI, USA.

No abstract available

MeSH terms

Administration, Intravenous
Atrial Fibrillation* / drug therapy
Atrial Flutter* / drug therapy
Diltiazem / adverse effects
Humans
Verapamil / adverse effects

Substances

Verapamil
Diltiazem